Macquarie Group’s Axogen AXGN Stock Holding History

Macquarie Group’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,050	Closed	-$67	–	1716
2024 Q4	$67	Buy	+4,050	New	+$57.3K	﹤0.01%	1635
2022 Q2	–	Sell	-1,932	Closed	-$15	–	2575
2022 Q1	$15	Hold	1,932	–	–	﹤0.01%	2445
2021 Q4	$18K	Hold	1,932	–	–	﹤0.01%	2413
2021 Q3	$31K	Hold	1,932	–	–	﹤0.01%	2353
2021 Q2	$42K	Buy	+1,932	New	+$39K	﹤0.01%	2194
2020 Q2	–	Sell	-69,338	Closed	-$721K	–	2360
2020 Q1	$721K	Buy	69,338 +9,885	+17%	+$126K	﹤0.01%	1177
2019 Q4	$1.06M	Sell	59,453 -3,665	-6%	-$54.2K	﹤0.01%	1220
2019 Q3	$788K	Buy	63,118 +2,508	+4%	+$41.3K	﹤0.01%	1280
2019 Q2	$1.2M	Buy	60,610 +17,123	+39%	+$366K	﹤0.01%	1164
2019 Q1	$916K	Buy	43,487 +4,676	+12%	+$85.4K	﹤0.01%	1214
2018 Q4	$793K	Buy	38,811 +11,017	+40%	+$345K	﹤0.01%	1211
2018 Q3	$1.02M	Buy	+27,794	New	+$1.21M	﹤0.01%	1196

Other funds holding AXGN

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Macquarie Group's AXGN Position: Q1 2025 in Review

Macquarie Group sold out of Axogen (AXGN) in Q1 2025, closing a stake of 4,050 shares — an estimated $67 sold.

Macquarie Group first reported a position in AXGN in Q3 2018 and held it in 12 quarters. The position peaked at $1.2M in Q2 2019. 181 funds tracked by Wall St. Rank hold AXGN as of Q1 2025.

Macquarie Group reported no remaining Axogen position as of Q1 2025 after selling out during the quarter.
Macquarie Group sold 4,050 Axogen shares in Q1 2025, an estimated $67.
Macquarie Group first reported a position in Axogen in Q3 2018 and held it in 12 quarters.
Macquarie Group's Axogen position peaked at $1.2M in Q2 2019.
181 funds tracked by Wall St. Rank held Axogen as of Q1 2025.

Based on Macquarie Group's 13F filing for Q1 2025, filed 15 May 2025.